Home
Krebs Biochemicals & Industries Ltd Board of Directors
Board of Directors at Krebs Biochemicals & Industries Ltd
Avinash Ravi
Non Executive Director
G V L Prasad
Independent Director
Jitendra Shah
Managing Director
Keyur Doshi
Company Sec. & Compli. Officer
R Ravi
Chairman (Non-Executive)
Key Highlights
- R T Ravi joins the board as Chairman & Non Executive Dir., in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Pabitra Bhattacharya joins the board as Non Independent Non Executive Director / MD, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Avinash Ravi joins the board as Non-Exec & Non-Independent Dir, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Popatlal M Kathariya joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Dipti Shah joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Krebs Biochemicals & Industries Ltd
NSE: KREBSBIO
Share Price
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 23 Dec 2025 | 69.23 |
| 22 Dec 2025 | 69.96 |
| 19 Dec 2025 | 69.89 |
| 18 Dec 2025 | 67.85 |
| 17 Dec 2025 | 69.95 |
| 16 Dec 2025 | 69.06 |
| 15 Dec 2025 | 70 |
| 12 Dec 2025 | 70.32 |
| 11 Dec 2025 | 70 |
| 10 Dec 2025 | 67.16 |
Company Fundamentals for Krebs Biochemicals & Industries Ltd
Market Cap
149 Cr
EPS
0.0
P/E Ratio (TTM)
0.0
P/B Ratio (TTM)
0.0
Day’s High
69.12
Day’s Low
69.06
DTE
-1.4
ROE
17.4
52 Week High
113.9
52 Week Low
63.55
ROCE
-19.2
Market Price of Krebs Biochemicals & Industries Ltd
1M
1Y
3Y
5Y
Monitoring Krebs Biochemicals & Industries Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Krebs Biochemicals & Industries Ltd News Hub
Krebs Biochemicals & Industries reports standalone net loss of Rs 5.17 crore in the June 2024 quarter
Net Loss of Krebs Biochemicals & Industries reported to Rs 5.17 crore in the quarter ended June 2024
Read more
07 Aug 24
Krebs Biochemicals & Industries schedules AGM
Krebs Biochemicals & Industries announced that the 32th Annual General Meeting (AGM) of the company
Read more
09 Sept 24
Krebs Biochemicals & Industries to conduct board meeting
Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 11 N
Read more
29 Oct 24
Krebs Biochemicals & Industries reports standalone net loss of Rs 5.76 crore in the September 2024 quarter
Net Loss of Krebs Biochemicals & Industries reported to Rs 5.76 crore in the quarter ended September
Read more
11 Nov 24
Document
Annual Reports
Annual Report 2024
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
FAQs for Board of Directors of Krebs Biochemicals & Industries Ltd
How are members of Krebs Biochemicals & Industries Ltd Board of Directors selected?
Members of the Krebs Biochemicals & Industries Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Krebs Biochemicals & Industries Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the Krebs Biochemicals & Industries Ltd Board of Directors?
Shareholders can interact with the Krebs Biochemicals & Industries Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the Krebs Biochemicals & Industries Ltd Board of Directors meet?
The Krebs Biochemicals & Industries Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the Krebs Biochemicals & Industries Ltd Board of Directors?
The Krebs Biochemicals & Industries Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at Krebs Biochemicals & Industries Ltd?
The current Board of Directors at Krebs Biochemicals & Industries Ltd includes R T Ravi( Chairman & Non Executive Dir.) ,Pabitra Bhattacharya( Non Independent Non Executive Director / MD) ,Avinash Ravi( Non-Exec & Non-Independent Dir) ,Popatlal M Kathariya( Independent Non Exe. Director) ,Dipti Shah( Independent Non Exe. Director) . The full list can be found on Krebs Biochemicals & Industries Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
